AR024350A1 - Antagonistas de los receptores de il-8 - Google Patents

Antagonistas de los receptores de il-8

Info

Publication number
AR024350A1
AR024350A1 ARP000102922A ARP000102922A AR024350A1 AR 024350 A1 AR024350 A1 AR 024350A1 AR P000102922 A ARP000102922 A AR P000102922A AR P000102922 A ARP000102922 A AR P000102922A AR 024350 A1 AR024350 A1 AR 024350A1
Authority
AR
Argentina
Prior art keywords
antagonists
receivers
chemokine
interleukin
refers
Prior art date
Application number
ARP000102922A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR024350A1 publication Critical patent/AR024350A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se refiere a nuevos compuestos de formula (1), y composiciones farmacéuticas de los mismos, así como a métodos de tratamiento de estados deenfermedad mediados por la quimiocina Interleucina-8 (IL-8).
ARP000102922A 1999-06-16 2000-06-14 Antagonistas de los receptores de il-8 AR024350A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14002499P 1999-06-16 1999-06-16

Publications (1)

Publication Number Publication Date
AR024350A1 true AR024350A1 (es) 2002-10-02

Family

ID=22489379

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000102922A AR024350A1 (es) 1999-06-16 2000-06-14 Antagonistas de los receptores de il-8

Country Status (19)

Country Link
EP (1) EP1185265A4 (es)
JP (1) JP2003501463A (es)
KR (1) KR20020015347A (es)
CN (1) CN1356899A (es)
AR (1) AR024350A1 (es)
AU (1) AU766235B2 (es)
BR (1) BR0011122A (es)
CA (1) CA2377386A1 (es)
CO (1) CO5190696A1 (es)
CZ (1) CZ20014472A3 (es)
HU (1) HUP0201582A3 (es)
IL (1) IL145762A0 (es)
MX (1) MXPA01013005A (es)
NO (1) NO20016052L (es)
NZ (1) NZ514696A (es)
PL (1) PL352213A1 (es)
TR (1) TR200103638T2 (es)
WO (1) WO2000076501A1 (es)
ZA (1) ZA200109480B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60326080D1 (en) 2002-10-09 2009-03-19 Schering Corp Thiadiazoldioxide und thiadiazoloxide als cxc- und cc-chemokinrezeptor liganden
DE10334309A1 (de) * 2003-07-28 2005-03-03 Aventis Pharma Deutschland Gmbh Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
US7094794B2 (en) 2003-07-28 2006-08-22 Sanofi-Aventis Deutschland Gmbh Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
CN1852905A (zh) 2003-08-21 2006-10-25 Osi制药公司 具有n－取代的苯并咪唑基的c－kit抑制剂
KR20060115346A (ko) 2003-08-21 2006-11-08 오에스아이 파마슈티컬스, 인코포레이티드 Ｎ―치환된 피라졸릴-아미딜-벤즈이미다졸릴 ｃ―ｋｉｔ억제제
US7442709B2 (en) 2003-08-21 2008-10-28 Osi Pharmaceuticals, Inc. N3-substituted imidazopyridine c-Kit inhibitors
TW200528450A (en) 2003-12-19 2005-09-01 Schering Corp Thiadiazoles as cxc-and cc-chemokine receptor ligands
AU2005299771A1 (en) 2004-10-21 2006-05-04 High Point Pharmaceuticals, Llc Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use
CN101193867A (zh) 2004-12-01 2008-06-04 Osi医药有限公司 N取代的苯并咪唑基c-Kit抑制剂和苯并咪唑组合库
EA201290073A1 (ru) 2009-08-24 2013-01-30 Эсэпиен Фармасьютикалз, Инк. Соединения мочевины, содержащие 5,6-бициклический гетероарил, как ингибиторы киназ
EP2377850A1 (en) 2010-03-30 2011-10-19 Pharmeste S.r.l. TRPV1 vanilloid receptor antagonists with a bicyclic portion
CN102060780B (zh) * 2010-12-27 2014-11-05 雅本化学股份有限公司 2-(n-取代)-氨基苯并咪唑衍生物的制备方法
CN111116502A (zh) * 2018-10-30 2020-05-08 中国石油化工股份有限公司 一步法合成苯骈三氮唑的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
BR9807083A (pt) * 1997-01-23 2000-04-18 Smithkline Beckman Corp Antagonistas ao receptor de il-8

Also Published As

Publication number Publication date
CO5190696A1 (es) 2002-08-29
MXPA01013005A (es) 2002-07-02
NO20016052D0 (no) 2001-12-11
EP1185265A1 (en) 2002-03-13
PL352213A1 (en) 2003-08-11
AU5616100A (en) 2001-01-02
NO20016052L (no) 2001-12-11
ZA200109480B (en) 2002-11-18
EP1185265A4 (en) 2004-02-04
WO2000076501A1 (en) 2000-12-21
IL145762A0 (en) 2002-07-25
CA2377386A1 (en) 2000-12-21
BR0011122A (pt) 2002-02-26
AU766235B2 (en) 2003-10-09
CZ20014472A3 (cs) 2002-06-12
KR20020015347A (ko) 2002-02-27
CN1356899A (zh) 2002-07-03
JP2003501463A (ja) 2003-01-14
HUP0201582A2 (hu) 2002-12-28
TR200103638T2 (tr) 2002-04-22
NZ514696A (en) 2004-03-26
HUP0201582A3 (en) 2003-02-28

Similar Documents

Publication Publication Date Title
BR0313109A (pt) Ciclobuteno-1,2-dionas 3,4-dissubstituìdas como ligandos de receptor de quimiocina de cxc
AR024350A1 (es) Antagonistas de los receptores de il-8
EA200500342A1 (ru) Гетероциклические замещённые пиперазины для лечения шизофрении
GT200100160A (es) Derivados 4-fenil-piridina.
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
CY1106514T1 (el) Ανταγωνιστες υποδοχεων il-8
BR9916159A (pt) Sulfonamidas de hidróxi-difenil-uréia comoantagonistas dos receptores de il-8
BRPI0514738A (pt) derivados de amida de 3-fenil-diidropirimido[4,5-d]pirimidinonas, sua fabricação e aplicação como agentes farmacêuticos
EA200200194A1 (ru) Антагонисты хемокинного рецептора и способы их применения
TR199901710T2 (xx) IL-8 resept�r antagonistleri.
BRPI0415773A (pt) derivados de indolinona e sua aplicação no tratamento de estados de doença tais como cáncer
DE60230722D1 (de) Il-8-rezeptor-antagonisten
ATE365730T1 (de) Neuartige verbindungen
EA200200933A1 (ru) Антагонисты рецептора il-8
BR0111279A (pt) Derivados da ciclohexilamina como antagonistas para o receptor do nmda seletivo ao subtipo
WO2005000231A3 (en) Il-8 receptor antagonists
AP1548A (en) Il-8 Receptor Antagonists.
WO2001068569A3 (en) Il-8 receptor antagonists
TR199901761T2 (xx) IL-8 resept�r antagonistleri.
AP2002002606A0 (en) INTERLEUKIN 8 RECEPTOR ANTAGONISTS
MY143477A (en) Il-8 receptor antagonists
ATE384066T1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
WO2004033436A8 (en) Sulfonylbenzodiazepinone acetamides as bradykinin antagonists
BRPI0415767A (pt) antagonistas de receptor de ccr-3
WO2001068033A3 (en) Il-8 receptor antagonists

Legal Events

Date Code Title Description
FA Abandonment or withdrawal